[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - March 2006

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 76-317 TOPIRAMATE TABLETS 50 MG   TEVA PHARMACEUTICALS USA 3/3/2006 
2 77-447 MOMETASONE FUROATE CREAM USP, 0.1%   G & W LABORATORIES, INC. 3/7/2006 
3 77-678 MOMETASONE FUROATE TOPICAL SOLUTION USP, 0.1%   G & W LABORATORIES, INC. 3/7/2006 
4 76-974 ONDANSETRON INJECTION USP, 2 MG/ML; PACKAGED IN 40 MG/20 ML MULTIPLE-DOSE VIALS   AMERICAN PHARMACEUTICAL PARTNERS, INC. 3/7/2006 
5 76-972 ONDANSETRON INJECTION USP, (PRESERVATIVE-FREE) 2 MG/ML; PACKAGED IN 4 MG/2 ML SINGLE-DOSE VIALS   AMERICAN PHARMACEUTICAL PARTNERS, INC. 3/7/2006 
6 77-614 CARVEDILOL TABLETS 3.125 MG, 6.25 MG, 12.5 MG, AND 25 MG   ZYDUS PHARMACEUTICALS USA, INC. 3/10/2006 
7 77-200 KETOTIFEN FUMARATE OPHTHALMIC SOLUTION 0.025%   ALCON RESEARCH, LTD. 3/17/2006 
8 77-511 TERBINAFINE HYDROCHLORIDE CREAM 1%   TARO PHARMACEUTICALS USA INC. 3/22/2006 
9 76-954 GATIFLOXACIN TABLETS 200 MG AND 400 MG   DR. REDDY'S LABORATORIES LIMITED 3/27/2006 
10 77-137 TERBINAFINE HYDROCHLORIDE TABLETS, 250 MG (BASE)   WATSON LABORATORIES, INC. 3/28/2006 
11 77-131 RIVASTIGMINE TARTRATE CAPSULES, 1.5 MG (BASE), 3 MG (BASE), 4.5 MG (BASE), AND 6 MG (BASE)   SUN PHARMACEUTICAL INDUSTRIES LTD. 3/29/2006 

 

Back to Top     Back to Approvals

Date created: April 12, 2006

horizonal rule